Dramatic regression of mesenteric abnormalities demonstrated on angiography following prednisolone and cyclophosphamide combination therapy in a patient with polyarteritis nodosa associated with Sjögren’s syndrome

References

• Garcia-Carrasco M, Ramos-Casals M, Rosas J, PaHares L, Calvo-Alen J, Cervera R, et al. Primary Sjögren syndrome: clinical and immunologic disease patterns in a cohort of 400 patients. Medi-cine (Baltimore). 2002;81:270–80.
   PubMed Web of Science ®Google Scholar
• Soliotis FC, Moutsopoulos HM. Sjogren's syndrome. Autoim-munity. 2004;37:305–7.
   PubMed Web of Science ®Google Scholar
• Lotti TM, Comacchi C, Ghersetich I. Cutaneous necrotizing vasculitis. Relation to systemic disease. Adv Exp Med Biol. 1999;455:115–25.
   Google Scholar
• Ramos-Casals M, Anaya JM, Garcia-Carrasco M, Rosas J, Bové A, Claver G, et al. Cutaneous vasculitis in primary Sjögren syndrome: classification and clinical significance of 52 patients. Medicine (Baltimore). 2004;83: 96–106.
   Google Scholar
• Ferri C, Mascia MT. Cryoglobulinemic vasculitis. Curr Opin Rheumatol. 2006;18:54–63.
   PubMed Web of Science ®Google Scholar
• Inoh M, Tokuda M, Maruoka T, Kinashi M, Kurata N, Okawa M, et al. Multiple colonic ulcers in a patient with Sjögren's syndrome (in Japanese). Ryumachi. 1995;35:585–8.
   PubMedGoogle Scholar
• Lightfoot RW Jr, Michel BA, Bloch DA, Hunder GG, Zvaifler NJ, McShane DJ, et al. The American College of Rheumatology 1990 criteria for the classification of polyarteritis nodosa. Arthritis Rheum. 1990;33:1088–93.
   PubMed Web of Science ®Google Scholar
• Jennette JC, Falk RJ, Andrassy K, Bacon PA, Churg J, Gross WL, et al. Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum. 1994;37:187–92.
   PubMed Web of Science ®Google Scholar
• Fauci AS, Doppman JL, Wolff SM. Cyclophosphamide-induced remissions in advanced polyarteritis nodosa. Am J Med. 1978;64:890–4.
   Google Scholar
• Fauci AS, Katz P, Haynes BF, Wolff SM. Cyclophosphamide therapy of severe systemic necrotizing vasculitis. N Engl J Med. 1979;301:235–8.
   PubMed Web of Science ®Google Scholar
• Leib ES, Restivo C, Paulus HE. Immunosuppressive and corticosteroid therapy of polyarteritis nodosa. Am J Med. 1979;67:941–7.
   Google Scholar
• Oriente P, Riccio A, Farinaro C, Farinaro E, Scarpa R, Vignone L, et al. Cyclophosphamide treatment in polyarteritis nodosa. Clin Rheumatol. 1986;5:193–200.
   PubMed Web of Science ®Google Scholar
• Guillevin L, Cohen P, Mahr A, Arène JP, Mouthon L, Puéchal X, et al. Treatment of polyarteritis nodosa and microscopic poly-angiitis with poor prognosis factors: a prospective trial comparing glucocorticoids and six or twelve cyclophosphamide pulses in sixty-five patients. Arthritis Rheum. 2003;49:93–100.
   Google Scholar
• Hekali P, Kajander H, Pajari R, Stenman S, Somer T. Diag-nostic significance of angiographically observed visceral aneurysms with regard to polyarteritis nodosa. Acta Radiol. 1991;32:143–8.
   Google Scholar
• Vázquez JJ, San Martin P, Barbado FJ, Gil A, Guerra J, Amalich F, et al. Angiographic findings in systemic necrotizing vasculitis. Angiology. 1981;32:773–9.
   Google Scholar
• Guillevin L, Lhote F, Gayraud M, Cohen P, Jarrousse B, Lortholary 0, et al. Prognostic factors in polyarteritis nodosa and Churg-Strauss syndrome. A prospective study in 342 patients. Medicine (Baltimore). 1996;75: 17–28.
   Google Scholar
• Terrier B, Lacroix C, Guillevin L, Hatron PY, Dhote R, Maillot F, et al. Club Rhumatismes et Inflammation. Diagnostic and prognostic relevance of neuromuscular biopsy in primary Sjögren's syndrome-related neuropathy. Arthritis Rheum. 2007;57:1520–9.
   Google Scholar
• Garcia-Bragado F, Vilardell M, Fonollosa V, Gallart MT, Rodr-igo MJ, Tornos J. Cryoglobulins in systemic and rheumatological diseases. Report of 70 cases (author's trans') (in Spanish). Med Clin (Bart). 1980;74: 209–13.
   Google Scholar
• Lamprecht P, Gause A, Gross WL. Cryoglobulinemic vasculitis. Arthritis Rheum. 1999;42:2507–16.
   PubMed Web of Science ®Google Scholar
• Travers RL, Allison DJ, Brettle RP, Hughes GR. Polyarteritis nodosa: a clinical and angiographic analysis of 17 cases. Semin Arthritis Rheum. 1979;8:184–99.
   PubMed Web of Science ®Google Scholar
• Sellar RJ, Mackay IG, Buist TA. The incidence of microaneu-rysms in polyarteritis nodosa. Cardiovasc Intervent Radiol. 1986;9:123–6.
   PubMed Web of Science ®Google Scholar
• Ewald EA, Griffin D, McCune WJ. Correlation of angiographic abnormalities with disease manifestations and disease severity in polyarteritis nodosa. J Rheumatol. 1987;14:952–6.
   Google Scholar
• Robins JM, Bookstein JJ. Regressing aneurysms in periarteritis nodosa. A report of 3 cases. Radiolog. 1972;104:39–42.
   Google Scholar
• Kato H, Koike S, Yamamoto M, Ito Y, Yano E. Coronary aneurysms in infants and young children with acute febrile mucocutaneous lymph node syndrome. J Pediatr. 1975;86:892–8.
   Google Scholar
• McClure PH, Westcott JL. Periarteritis nodosa with perirenal hemorrhage: a case report with angiographic findings. J Urol. 1969;102:126–9.
   PubMed Web of Science ®Google Scholar
• Hagspiel KD, Angle JF, Spinosa DJ, Matsumoto AH. Diagnosis please. Case 13: polyarteritis nodosa-systemic necrotizing vas-culitis with involvement of hepatic and superior mesenteric arteries. Radiology. 1999;212: 359–64.
   Google Scholar
• Yamada H, Oka M, Mori S, Takahashi T, Kuwata S, Aizawa C, et al. A young female case of polyarteritis nodosa strongly sus-pected by typical angiographic findings which improved rapidly after prednisolone and cyclophosphamide therapy. Intern Med. 1992;31:431–3.
   PubMed Web of Science ®Google Scholar
• Harada M, Yoshida H, Ikeda H, Yoshida T, Takedatsu H, Nagamatsu H, et al. Polyarthritis nodosa with mesenteric aneu-rysms demonstrated by angiography: report of a case and successful treatment of the patient with prednisolone and cyclo-phosphamide. J Gastroenterol. 1999;34:702–5.
   PubMed Web of Science ®Google Scholar
• Raza K, Carruthers DM, Exley AR, 'Thambyrajah J, Bacon PA, Rowe IF. Dramatic aneurysm regression in polyarteritis nodosa following high dose pulse cyclophosphamide. J Rheumatol. 2000;27:1320–1.
   Google Scholar
• Hughes LB, Bridges SL Jr. Polyarteritis nodosa and microscopic polyangiitis: etiologic and diagnostic considerations. Curr Rheumatol Rep. 2002;4(1):75–82.
   PubMedGoogle Scholar
• Rose GA. The natural history of polyarteritis. Br Med J. 1957;2:1148–52.
   PubMedGoogle Scholar
• Frohnert PP, Sheps SG. Long-term follow-up study of periarte-ritis nodosa. Am J Med. 1967;43:8–14.
   PubMed Web of Science ®Google Scholar
• Gayraud M, Guillevin L, le Toumelin P, Cohen P, Lhote F, Casassus P, et al. Long-term followup of polyarteritis nodosa, microscopic polyangiitis, and Churg-Strauss syndrome: analysis of four prospective trials including 278 patients. Arthritis Rheum. 2001;44:666–75.
   PubMed Web of Science ®Google Scholar
• Bourgarit A, Le Toumelin P, Pagnoux C, Cohen P, Mahr A, Le Guern V, et al. Deaths occurring during the first year after treatment onset for polyarteritis nodosa, microscopic polyangiitis, and Churg-Strauss syndrome: a retrospective analysis of causes and factors predictive of mortality based on 595 patients. Medi-cine (Baltimore). 2005;84:323–30.
   PubMed Web of Science ®Google Scholar